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Background: Substantial efforts have been made to reduce the risk of infection after total hip arthroplasty
(THA), including pre-operative patient optimization, skin preparation with alcohol-based solutions,
perioperative antibiotics, and minimizing wound drainage with novel sutures and dressings. While these
approaches have been effective in primary THA, their effects on revision THA to improve surgical site
infection (SSI) rates are less clear. Therefore, the purpose of this study was to identify the annual rates and
trends of: (I) overall; (II) deep; and (III) superficial SSIs following revision THA using the most recent results
(2011 to 2016) from a large, nationwide database.
Methods: The National Surgical Quality Improvement Program (NSQIP) database was queried for all
revision THA cases (CPT code 27134) between 2011 and 2016, yielding 8,562 cases. A steady increase in
the total number of revision THA cases was observed from 2011 to 2016 (750 vs. 1,951, 260%). Cases with
reported superficial and/or deep SSI were analyzed separately and then combined to evaluate overall SSI
rates. The infection incidence for each year was calculated. After an overall 6-year correlation and trends
analysis, univariate analysis was performed to compare the most recent year, 2016, with each of the preceding
5 years. Additionally, percent differences between 2016 and each previous year were calculated to evaluate
rate changes. Pearson correlation coefficients and chi-squared tests were used to determine correlation and
statistical significance which was maintained at a P value less than 0.05.
Results: There were 217 cases out of 8,562 (2.53% of all cases) complicated by any SSI. Overall, there was
an inverse correlation between combined SSI rate and year, however, this was not statistically significant
(P>0.05). The lowest incidence was in 2016 (n=41, 2.10%), while the highest incidence was in 2014 (n=45,
2.86%). The combined SSI rate in 2016 decreased by 22% when compared to 2015 (2.10% vs. 2.69%,
P>0.05). A larger, 27% decrease in rate was found between 2016 and 2014 (2.10% vs. 2.86%, P>0.05). For
deep SSI, there was an inverse correlation between rate and year of surgery, however, this was not statistically
significant (P>0.05). The deep SSI incidence over the 5 years was 1.38% (118 out of 8,562 cases). There was
a 35% decrease in deep SSI rate from 2016 to 2015 (0.92% vs. 1.43%, P>0.05). A larger, 53% decrease, was
seen between 2016 and 2014 (0.92% vs. 1.04%, P<0.01). For superficial SSI, there was an inverse correlation
between rate and year, however, this was not statistically significant (P>0.05). In this 6-year period, 99 cases
out of 8,562 were complicated by a superficial SSI; an incidence of 1.16%. The lowest incidence occurred in
2014 (n=14, 0.89%), while 2012 had the highest incidence (n=17, 1.61%). The rate in 2016 decreased by 6%
when compared to 2015 (1.18% vs. 1.07%, P>0.05). A larger, 27% decrease in rate was observed between
2016 and 2012 (1.18% vs. 1.61%, P>0.05).
Conclusions: Revision total hip arthroplasties exhibited a trend towards decreasing overall SSI nationwide
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between 2011 and 2016. Deep SSI rates had marked improvements, specifically between 2014 and 2016. This
trend indicates some benefit from pre- and post-operative infection preventative strategies, but importantly,
indicates continued room for improvement. Due to the potentially devastating complications associated with
infection in revision THAs, further research is required to identify revision-specific strategies to lower the
rates of SSIs.
Keywords: Infection; surgical site infection (SSI); PJI; revision total hip arthroplasty (revision THA); trends
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Introduction
Although uncommon, surgical site infections (SSIs)
are severe complications following revision total hip
arthroplasty (THA), and can lead to increased morbidity
and mortality as well as the need for additional surgeries.
Revision surgeries in particular are of concern for infection,
as an extensive surgical approach can impose substantial
insult to the surrounding soft tissue envelope, creating a
greater inherent risk for SSIs than primary procedures.
Because of the post-operative consequences of SSIs, a
number of preventive infection measures have been adopted
over the years, such as prophylactic antibiotic therapy, preoperative patient optimization, operating room filtration
systems, and many others (1-8). Intra-operative strategies
include irrigation, intra-wound powdered antibiotics, and
newer suture types and techniques. To protect the wound,
different dressing types, such as negative pressure wound
therapy, has been shown to significantly reduce SSI risks
[relative risk 0.43, 95% confidence interval (CI): 0.32 to
0.57, P<0.0001] (9). Although a number of different SSI
preventative strategies have been adopted, there is still
conflicting evidence regarding THA infection trends,
particularly in revision cases (10).
The current literature reports infection rates after
primary THA to be between 0.2% and 0.7%. However, that
number varies substantially between 0.95% and 22% for
revision THAs (10,11). Phillips et al. investigated Medicare
claims data for revision THA between 1995 and 1996 and
found infections rates to be 1.1% (12). In more recent data
from 2000 to 2011, Everhart et al. investigated risk factors
for infection in 652 revision THA and found the infection
incidence to be 6.2% (13). Due to these inconsistencies,
the importance to track our progress in fighting infections,
and the need for more up-to-date analyses, it is critical to
continuously assess nationwide infection trends.
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Although the current literature shows an increasing
incidence of infection after revision THA, the data is varied
and not current. Due to the increased mortality associated
with infections after revision THA, we need to re-evaluate
if our current SSI prevention strategies have slowed down
the increasing trend of infection. Furthermore, although
specific measures and their direct effects on infection
incidences have often been investigated, the collective
influence of all these efforts over an extended period of time
has not been well-assessed in the literature. Therefore, the
question than remains, have we been able to slow down the
increasing trend of SSI rates in revision THA? To answer
this, we tracked the annual rates and trends of: (I) overall; (II)
deep; and (III) superficial SSIs following revision THA.
Methods
Data source
The American College of Surgeons (ACS) National
Surgical Quality Improvement Program (NSQIP) database
prospectively collects data from millions from community
and academic centers across the United States. Using Current
Procedural Terminology (CPT) code 27134, patients who
underwent revision THAs were identified from the database
from January 1, 2011 to December 31, 2016. The query
results in 8,562 cases, which were initially stratified according
to the year of surgery. A 260% increase in the annual number
of revision THA cases performed was observed from 2011
(750 cases) to 2016 (1,951 cases; Figure 1). Because the
data was de-identified and publicly available, this study was
deemed exempt by the Institutional Review Board.
Outcomes of interest
SSIs that occurred within 30 post-operative days for
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analysis with Pearson’s chi-squared tests. Percent differences
between infection rates in 2016 and infection rates of each
previous year were also calculated to evaluate rate changes.
Data analyses were conducted using SPSS version 22.0 for
Windows (IBM, Armonk, New York, USA) and statistical
significance was maintained at a P value of less than 0.05.

Total number of rTHA cases
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Figure 1 Number of revision total hip arthroplasties per year.

Table 1 Annual incidence of surgical site infections (SSIs)
Year
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Total number of Total number of Total number of
superficial SSI (%) deep SSI (%) combined SSI (%)

2011

8 (1.07)

9 (1.20)

17 (2.27)

2012

17 (1.61)

11 (1.04)

28 (2.64)

2013

15 (1.01)

24 (1.62)

39 (2.63)

2014

14 (0.89)

31 (1.97)

45 (2.86)

2015

22 (1.26)

25 (1.43)

47 (2.69)

2016

23 (1.18)

18 (0.92)

41 (2.10)

Total

99 (1.16)

118 (1.38)

217 (2.53)

each patient were extracted from the database. SSIs were
classified as either deep or superficial incisional SSIs. Deep
SSIs included those with purulent drainage, or a deep
incision that dehisces, or an infection found on reoperation.
Superficial SSIs were identified by swelling or erythema,
which required less aggressive treatment. An overall deep
plus superficial SSI rate was also analyzed.
Data analyses
For each year, overall, deep, and superficial SSI incidences
were calculated. Correlative analyses associating the
year of surgery and infection incidence were determined
with Pearson correlation coefficients. Annual infection
incidences for each type of SSI were plotted against the year
of surgery for trends analyses.
The infection incidence of the most recent year, 2016,
was compared to the preceding 4 years utilizing univariate
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Over the 6-year study period, a total of 217 (2.53%) out
of 8,562 revision THA cases were complicated by any SSI.
The lowest incidence of overall SSIs was in the most recent
year tabulated, 2016 (2.10%), while the highest incidence
was in the earliest year, 2014 (2.86%; Table 1).
An inverse correlation between combined SSI rate
and year was noted, however, this was not found to be
statistically significant (P>0.05) (Figure 2).
The combined SSI rate in 2016 decreased by 22% when
compared to 2015 (2.10% vs. 2.69%, P>0.05). A larger, 27%
decrease in rate was found between 2016 and 2014 (2.10%
vs. 2.86%, P>0.05) (Table 2).
Deep SSIs
For deep SSIs, the incidence over 5 years was 1.38%
(118 out of 8,562 cases). There was an inverse correlation
between rate and year of surgery, however, this was not
found to be significant (P>0.05; Figure 2).
There was a 35% decrease in deep SSI rate from 2015
to 2016 (1.43% vs. 0.92%, P>0.05). A larger, 53% decrease
was seen between 2016 and 2014 (0.92% vs. 1.04%, P<0.01)
(Table 3).
Superficial SSIs
In this 6-year period, 99 cases out of 8,562 were
complicated by a superficial SSI; an incidence of 1.16%.
The lowest superficial SSI incidence occurred in 2014 (n=14,
0.89%), while 2012 had the highest incidence (n=17, 1.61%)
(Table 1).
There was an inverse correlation between rate and year,
however, this was not statistically significant (P>0.05).
The rate in 2016 decreased by 6% when compared to
2015 (1.18% vs. 1.26%, P>0.05). A larger, 27% decrease in
rate was observed between 2016 and 2012 (1.18% vs. 1.07%,
P>0.05) (Table 4).
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Trends in SSI rates from 2011 to 2016
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Figure 2 Trends in SSI rates after revision total hip arthroplasty (THA) from 2011 to 2016. SSI, surgical site infection.

Table 2 Overall surgical site infection rate in 2016 compared to preceding 4 years
Year

Overall SSI cases, n (%)

Percent difference (%)

P value

2016/2015

41 (2.10)/47 (2.69)

22

0.241c

2016/2014

41 (2.10)/45 (2.86)

27

0.146c

2016/2013

41 (2.10)/39 (2.63)

20

0.311c

2016/2012

41 (2.10)/28 (2.64)

21

0.342c

2016/2011

41 (2.10)/17 (2.27)

7

0.791c

Deep SSI cases, n (%)

Percent difference (%)

P value

2016/2015

18 (0.92)/25 (1.43)

36

0.149c

2016/2014

18 (0.92)/11 (1.04)

53

0.008c

2016/2013

18 (0.92)/31 (1.97)

43

0.066c

2016/2012

18 (0.92)/9 (1.20)

11

0.755c

2016/2011

18 (0.92)/24 (1.62)

23

0.421c

c

, Pearson’s chi-square test.

Table 3 Deep surgical site infection rates in 2016 compared to the preceding 4 years
Year

c

, Pearson’s chi-square test.
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Table 4 Superficial surgical site infection rates in 2016 compared to the preceding 4 years
Year

Superficial SSI cases, n (%)

Percent difference (%)

P value

2016/2015

23 (1.18)/22 (1.26)

6

0.822c

2016/2014

23 (1.18)/17 (1.61)

32

0.404c

2016/2013

23 (1.18)/14 (0.89)

16

0.641c

2016/2012

23 (1.18)/8 (1.07)

27

0.329c

2016/2011

23 (1.18)/15 (1.01)

10

0.806c

c

, Pearson’s chi-square test.

Discussion
Poor functional outcomes and increased rates of mortality
after infection for total joint arthroplasty have led to a
wide range of infection prevention measures which have
now been the new standard over the past several years.
Despite the fact that revision arthroplasty surgery is a risk
within itself for SSI, there is limited literature evaluating
the annual rates of infections after these procedures.
Therefore, a newer, up-to-date analysis was needed
to assess infection trends. The results from this study
identified a decreasing trend both superficial and deep
SSIs after revision THAs. For deep SSIs in particular, a
significant, 53%, decrease (0.92% versus 1.04%, P<0.01)
was noted from 2014 to 2016.
There are some limitations to this study. Because the
data evaluated was collected from a number of different
centers throughout the country, it was not possible to
ensure the same infection classifications and criteria were
used at each site. Nevertheless, because infections are
relatively rare post-operative complications, it is necessary
to use a large database such as NSQIP. Furthermore,
although there is potential for data collection heterogeneity,
because the data was collected from a large sampling of
hospitals, it provides greater, nationwide generalizability
than institution or region specific data. Additionally, the
data analyzed included up to 30 post-operative day, so there
is a potential for missed infections that occurred outside
of this window. Nevertheless, to the best of the author’s
knowledge, this study provides the most up-to-date trends
analyses in infections after revision THA.
Some of the current evidence supports the decreasing
trend of infection after revision THA. Pugely et al. reviewed
1,036 revision THAs in the years prior to our study, 2005 to
2010, using the same NSQIP database. They found a higher
incidence of SSI, 2.9% and 1.7% for both overall and
deep respectively (5). Additionally, Rasouli et al. evaluated
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SSIs using a Nationwide Inpatient sample database from
2002 to 2010 and found that over this time period, logistic
regression showed that SSI rates declined with year.
Furthermore, the authors of that study also evaluated
infection trends in primary THA, and also found decreasing
rates of overall, deep and, superficial infections.
In contrast to our study, Wolf et al. found increasing
rates of complications following revision THA. In 337,874
revision THAs investigated between 1991 and 2008 using
the United States Medicare Beneficiaries database, the
group discovered a >20% increase in the readmission rate
after revision THA. Over this time period, there was a
steady increase in infection rates of 1.1%, 1.3%, 1.6%,
1.8%, 2.1%, and 2.9% respectively (P<0.0001) (14).
Some studies have identified important risk factors that
could increase the rate of infection after revision THA.
Kosashvili et al. reviewed 749 revision THAs at a mean follow
up of 13.2±5.9 years, and found that infection occurred in
2.14% of these revisions. Interestingly, there was a direct
and significant correlation between the number of revision
THAs and the incidences of infection. Compared to a single
revision surgery, infection rates increased by 42%, 84% and
480.7% after a 2nd 3rd and 4th or greater operation (15).
Conclusions
Revision total hip arthroplasties exhibited a trend, although
without statistical significance, of decreasing overall
SSIs nationwide between 2011 and 2016. Deep SSI rates
specifically had marked improvement between 2014 and
2016. This trend indicates some benefit from pre- and postoperative infection prevention strategies, but importantly
indicates continued need for improvement. Due to the
potentially devastating complications associated with
infection in revision THAs, further research is necessary to
identify revision-specific strategies to lower the rates of SSIs.
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